The cyclic peptide mallotumide A inhibits colon and breast cancer cell growth and motility by targeting cellular respiration and lipogenesis
Open Access
- 19 November 2025
- journal article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 40774
Abstract
We have recently isolated, and determined the structure of a cycloheptapeptide, Mallotumide A from the Mallotus spodocarpus root extract. Here we reported the anti-cancer activity of Mallotumide A in highly invasive colon cancer, HCT116 and triple-negative breast cancer, MDA-MB-231 cell lines. Mallotumide A, at concentrations of 1 nM and 10 nM, completely inhibited the clonogenic growth, migration, and invasion of HCT116 and MDA-MB-231 cells, respectively. While the compound interfered with cell cycle progression without inducing apoptosis, exposure to 10 nM Mallotumide A for 48 h reduced the expression of two key lipogenic enzymes, ACC1 and FASN, by approximately 50% in both cell lines. The downregulation of ACC1 and FASN was accompanied by a 50% reduction in intracellular triglyceride levels while the cholesterol levels remained unaffected. Mallotumide A also moderately decreased AMP-activated protein kinase (AMPK) and ATP levels. Extracellular flux analysis revealed that acute exposure of both cancer cell lines to 1 nM and 10 nM Mallotumide A for 24 h markedly lowered the oxygen consumption rate. This was accompanied by reductions in basal and ATP-linked respiration, maximal respiration, and mitochondrial spare respiratory capacity. Mallotumide A also decreased the extracellular acidification rate, affecting both basal glycolysis and the glycolytic reserve. These findings suggest that the anti-cancer effects of Mallotumide A are associated with disruptions in cellular energy metabolism and the de novo lipogenesis pathway in cancer cells. This study underscores the potential of Mallotumide A as a novel anti-cancer agent.Keywords
Funding Information
- Science Achievement PhD scholarship program
- Program Management Unit for Human Resources & Institutional Development, Research and Innovation (B16F640120, B16F640120, B16F640120, B16F640120)
- Center of Excellence for Innovation in Chemistry (PERCH-CIC), Ministry of Higher Education, Science, Research and Innovation, and Mahidol University
This publication has 58 references indexed in Scilit:
- Acetyl-CoA carboxylase 1 depletion suppresses de novo fatty acid synthesis and mitochondrial β-oxidation in castration-resistant prostate cancer cellsJournal of Biological Chemistry, 2022
- Targeting of HER/ErbB family proteins using broad spectrum Sec61 inhibitors coibamide A and apratoxin ABiochemical Pharmacology, 2021
- Adipose triglyceride lipase activity regulates cancer cell proliferation via AMP-kinase and mTOR signalingBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2020
- Inhibition of fatty acid synthesis arrests colorectal neoplasm growth and metastasis: Anti-cancer therapeutical effects of natural cyclopeptide RA-XIIBiochemical and Biophysical Research Communications, 2019
- Suppressed de novo lipogenesis by plasma membrane citrate transporter inhibitor promotes apoptosis in HepG2 cellsFEBS Open Bio, 2018
- Cyclopeptide RA-V inhibits cell adhesion and invasion in both estrogen receptor positive and negative breast cancer cells via PI3K/AKT and NF-κB signaling pathwaysBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2015
- Nannocystin A: an Elongation Factor 1 Inhibitor from Myxobacteria with Differential Anti‐Cancer PropertiesAngewandte Chemie International Edition, 2015
- Targeting Lactate Dehydrogenase-A Inhibits Tumorigenesis and Tumor Progression in Mouse Models of Lung Cancer and Impacts Tumor-Initiating CellsCell Metabolism, 2014
- Matrix Metalloproteinases: Regulators of the Tumor MicroenvironmentCell, 2010
- Electron microscopic localization of pyruvate carboxylase in rat liver and Saccharomyces cerevisiae by immunogold proceduresArchives of Biochemistry and Biophysics, 1991